Our study aimed to elucidate the association between anti-α-fodrin antibodies and clinical as well as immunological perturbations in SLE, particularly their relationship with anti-Ro/anti-Ro52 antibodies and chemokine levels. This evidence concerns the gene CALR and systemic lupus erythematosus.